Cite Filings / CRSP / 9999999995-17-003132

Feed Companies Filings Check

Sign in

EFFECT

Notice of Effectiveness

CRISPR Therapeutics AG Filed 2017-12-04 Acc 9999999995-17-003132

Documents 1

EFFECT Notice of Effectiveness , xslEFFECTX01/primary_doc.xml

Around this filing

2017-12-06 SC 13D/A Beneficial Ownership Report
2017-12-05 4 Chief Executive Officer acquired 26,667 shares (grant or award)
2017-12-04 EFFECT Notice of Effectiveness
2017-12-01 CORRESP Correspondence Between Filers and SEC Staff
2017-12-01 S-3/A Registration Statement
2017-12-01 CORRESP Correspondence Between Filers and SEC Staff
2016-10-18 EFFECT Notice of Effectiveness

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslEFFECTX01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…